_id
6919ec213c536f8df23183c9
Ticker
OBI.LSE
Name
Ondine Biomedical Inc
Exchange
LSE
Address
1100 Melville Street, Vancouver, BC, Canada, V6E 4A6
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://ondinebio.com
Description
Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections. In addition, the company offers a pipeline of products for various indications, including burns, ventilator tube, and sinus; and serious and chronic wounds, chronic sinusitis, ventilator-associated pneumonia VAP, and central line bloodstream infections, as well as catheter-associated urinary tract infection. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.
Last Close
87500
Volume
7971
Current Price
7.95
Change
0
Last Updated
2025-12-30T11:19:30.860Z
Image
https://logo.clearbit.com/ondinebio.com
Ipo Date
-
Market Cap
45357112
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
667526
Cost Of Revenue
370785
Gross Profit
296740
Operating Expenses
6811575
Operating Income
-6514835
Interest Expense
14023
Pretax Income
-6358891
Net Income
-6358891
Eps
-0.020981279418776328
Dividends Per Share
-
Shares Outstanding
518366964
Income Tax Expense
-
EBITDA
-6187245
Operating Margin
-975.9672282427949
Total Other Income Expense Net
155943
Cash
9767000
Short Term Investments
-
Receivables
513000
Inventories
1272000
Total Current Assets
12188000
Property Plant Equipment
597000
Total Assets
12822000
Payables
1586000
Short Term Debt
168000
Long Term Debt
-
Total Liabilities
5945000
Equity
6877000
Bs_currency_symbol
CAD
Depreciation
157626
Change In Working Capital
1062033
Cash From Operations
-4573156
Capital Expenditures
206.72
Cash From Investing
210.18
Cash From Financing
9124345
Net Change In Cash
4718735
Cf_currency_symbol
-
PE
-
PB
350.3624200159953
ROE
-92.46606078231787
ROA
-49.593596942754644
FCF
-4573362.72
Fcf Percent
-6.851212866614933
Piotroski FScore
1
Health Score
23
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
667526
Quarters > 0 > income Statement > cost Of Revenue
370785
Quarters > 0 > income Statement > gross Profit
296740
Quarters > 0 > income Statement > operating Expenses
6811575
Quarters > 0 > income Statement > operating Income
-6514835
Quarters > 0 > income Statement > interest Expense
14023
Quarters > 0 > income Statement > pretax Income
-6358891
Quarters > 0 > income Statement > net Income
-6358891
Quarters > 0 > income Statement > eps
-0.020981279418776328
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
303074511
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-6187245
Quarters > 0 > income Statement > operating Margin
-975.9672282427949
Quarters > 0 > income Statement > total Other Income Expense Net
155943
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
9767000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
513000
Quarters > 0 > balance Sheet > inventories
1272000
Quarters > 0 > balance Sheet > total Current Assets
12188000
Quarters > 0 > balance Sheet > property Plant Equipment
597000
Quarters > 0 > balance Sheet > total Assets
12822000
Quarters > 0 > balance Sheet > payables
1586000
Quarters > 0 > balance Sheet > short Term Debt
168000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5945000
Quarters > 0 > balance Sheet > equity
6877000
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-6358891
Quarters > 0 > cash Flow > depreciation
157626
Quarters > 0 > cash Flow > change In Working Capital
1062033
Quarters > 0 > cash Flow > cash From Operations
-4573156
Quarters > 0 > cash Flow > capital Expenditures
206.72
Quarters > 0 > cash Flow > cash From Investing
210.18
Quarters > 0 > cash Flow > cash From Financing
9124345
Quarters > 0 > cash Flow > net Change In Cash
4718735
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.020981279418776328
Quarters > 0 > ratios > PB
350.3624200159953
Quarters > 0 > ratios > ROE
-92.46606078231787
Quarters > 0 > ratios > ROA
-49.593596942754644
Quarters > 0 > ratios > FCF
-4573362.72
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-6.851212866614933
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
865229
Quarters > 1 > income Statement > cost Of Revenue
606364
Quarters > 1 > income Statement > gross Profit
258865
Quarters > 1 > income Statement > operating Expenses
8146000
Quarters > 1 > income Statement > operating Income
-7887000
Quarters > 1 > income Statement > interest Expense
22159
Quarters > 1 > income Statement > pretax Income
-7818000
Quarters > 1 > income Statement > net Income
-7818000
Quarters > 1 > income Statement > eps
-0.03237682683905595
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
241469000
Quarters > 1 > income Statement > income Tax Expense
-3301000
Quarters > 1 > income Statement > EBITDA
-4217941
Quarters > 1 > income Statement > operating Margin
-911.5505837182989
Quarters > 1 > income Statement > total Other Income Expense Net
68492
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1218000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
238000
Quarters > 1 > balance Sheet > inventories
1288000
Quarters > 1 > balance Sheet > total Current Assets
3222000
Quarters > 1 > balance Sheet > property Plant Equipment
767000
Quarters > 1 > balance Sheet > total Assets
4025000
Quarters > 1 > balance Sheet > payables
1884000
Quarters > 1 > balance Sheet > short Term Debt
351000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4006000
Quarters > 1 > balance Sheet > equity
19000
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-7818298
Quarters > 1 > cash Flow > depreciation
286059
Quarters > 1 > cash Flow > change In Working Capital
19137
Quarters > 1 > cash Flow > cash From Operations
-7135381
Quarters > 1 > cash Flow > capital Expenditures
10074
Quarters > 1 > cash Flow > cash From Investing
-10072
Quarters > 1 > cash Flow > cash From Financing
5323332
Quarters > 1 > cash Flow > net Change In Cash
-1860190
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.03237682683905595
Quarters > 1 > ratios > PB
101035.71315789473
Quarters > 1 > ratios > ROE
-41147.36842105263
Quarters > 1 > ratios > ROA
-194.23602484472048
Quarters > 1 > ratios > FCF
-7145455
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-8.258455276002076
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
766822
Quarters > 2 > income Statement > cost Of Revenue
592678
Quarters > 2 > income Statement > gross Profit
174144
Quarters > 2 > income Statement > operating Expenses
6878000
Quarters > 2 > income Statement > operating Income
-6704000
Quarters > 2 > income Statement > interest Expense
17808
Quarters > 2 > income Statement > pretax Income
-6443000
Quarters > 2 > income Statement > net Income
-6443000
Quarters > 2 > income Statement > eps
-0.032199222381033295
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
200098000
Quarters > 2 > income Statement > income Tax Expense
3.35
Quarters > 2 > income Statement > EBITDA
-6424000
Quarters > 2 > income Statement > operating Margin
-874.2576504064829
Quarters > 2 > income Statement > total Other Income Expense Net
260220
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
2981000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
326000
Quarters > 2 > balance Sheet > inventories
1066000
Quarters > 2 > balance Sheet > total Current Assets
4750000
Quarters > 2 > balance Sheet > property Plant Equipment
949000
Quarters > 2 > balance Sheet > total Assets
5734000
Quarters > 2 > balance Sheet > payables
1363000
Quarters > 2 > balance Sheet > short Term Debt
382000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3649000
Quarters > 2 > balance Sheet > equity
2085000
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-6443288
Quarters > 2 > cash Flow > depreciation
279022
Quarters > 2 > cash Flow > change In Working Capital
809079
Quarters > 2 > cash Flow > cash From Operations
-5268233
Quarters > 2 > cash Flow > capital Expenditures
287.58
Quarters > 2 > cash Flow > cash From Investing
287.58
Quarters > 2 > cash Flow > cash From Financing
3957784
Quarters > 2 > cash Flow > net Change In Cash
-1439723
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.032199222381033295
Quarters > 2 > ratios > PB
762.9635971223022
Quarters > 2 > ratios > ROE
-309.01678657074336
Quarters > 2 > ratios > ROA
-112.36484129752355
Quarters > 2 > ratios > FCF
-5268520.58
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-6.8705913236709435
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
431846
Quarters > 3 > income Statement > cost Of Revenue
475234
Quarters > 3 > income Statement > gross Profit
-43387
Quarters > 3 > income Statement > operating Expenses
8059000
Quarters > 3 > income Statement > operating Income
-8102000
Quarters > 3 > income Statement > interest Expense
20179
Quarters > 3 > income Statement > pretax Income
-7971000
Quarters > 3 > income Statement > net Income
-7971000
Quarters > 3 > income Statement > eps
-0.04093654347870745
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
194716000
Quarters > 3 > income Statement > income Tax Expense
6.71
Quarters > 3 > income Statement > EBITDA
-7794000
Quarters > 3 > income Statement > operating Margin
-1876.1317691955003
Quarters > 3 > income Statement > total Other Income Expense Net
131169
Quarters > 3 > income Statement > currency_symbol
GBX
Quarters > 3 > balance Sheet > cash
4439000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
97000
Quarters > 3 > balance Sheet > inventories
1088000
Quarters > 3 > balance Sheet > total Current Assets
6208000
Quarters > 3 > balance Sheet > property Plant Equipment
1163000
Quarters > 3 > balance Sheet > total Assets
7406000
Quarters > 3 > balance Sheet > payables
233000
Quarters > 3 > balance Sheet > short Term Debt
401000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3261000
Quarters > 3 > balance Sheet > equity
4145000
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-7971025.96
Quarters > 3 > cash Flow > depreciation
307741.9
Quarters > 3 > cash Flow > change In Working Capital
-1104843.83
Quarters > 3 > cash Flow > cash From Operations
-8247489.73
Quarters > 3 > cash Flow > capital Expenditures
175564.07
Quarters > 3 > cash Flow > cash From Investing
-175564.07
Quarters > 3 > cash Flow > cash From Financing
-212896.25
Quarters > 3 > cash Flow > net Change In Cash
-9084387.38
Quarters > 3 > cash Flow > currency_symbol
GBX
Quarters > 3 > ratios > PE
-0.04093654347870745
Quarters > 3 > ratios > PB
373.46012062726174
Quarters > 3 > ratios > ROE
-192.30398069963812
Quarters > 3 > ratios > ROA
-107.62894950040507
Quarters > 3 > ratios > FCF
-8423053.8
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-19.50476280896431
Quarters > 3 > health Score
22
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2049000
Annuals > 0 > income Statement > cost Of Revenue
728000
Annuals > 0 > income Statement > gross Profit
1321000
Annuals > 0 > income Statement > operating Expenses
20765000
Annuals > 0 > income Statement > operating Income
-19444000
Annuals > 0 > income Statement > interest Expense
47000
Annuals > 0 > income Statement > pretax Income
-19098000
Annuals > 0 > income Statement > net Income
-19098000
Annuals > 0 > income Statement > eps
-0.06954818081507351
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
274601000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-18486000
Annuals > 0 > income Statement > operating Margin
-948.9507076622743
Annuals > 0 > income Statement > total Other Income Expense Net
346000
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
9767000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
513000
Annuals > 0 > balance Sheet > inventories
1272000
Annuals > 0 > balance Sheet > total Current Assets
12188000
Annuals > 0 > balance Sheet > property Plant Equipment
597000
Annuals > 0 > balance Sheet > total Assets
12822000
Annuals > 0 > balance Sheet > payables
1586000
Annuals > 0 > balance Sheet > short Term Debt
168000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5945000
Annuals > 0 > balance Sheet > equity
6877000
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-19098000
Annuals > 0 > cash Flow > depreciation
565000
Annuals > 0 > cash Flow > change In Working Capital
1913000
Annuals > 0 > cash Flow > cash From Operations
-15490000
Annuals > 0 > cash Flow > capital Expenditures
10000
Annuals > 0 > cash Flow > cash From Investing
-10000
Annuals > 0 > cash Flow > cash From Financing
21737000
Annuals > 0 > cash Flow > net Change In Cash
6788000
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.06954818081507351
Annuals > 0 > ratios > PB
352.185665261015
Annuals > 0 > ratios > ROE
-277.7083030391159
Annuals > 0 > ratios > ROA
-148.94712213383247
Annuals > 0 > ratios > FCF
-15500000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-7.564665690580771
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1203000
Annuals > 1 > income Statement > cost Of Revenue
500000
Annuals > 1 > income Statement > gross Profit
703000
Annuals > 1 > income Statement > operating Expenses
15508000
Annuals > 1 > income Statement > operating Income
-14805000
Annuals > 1 > income Statement > interest Expense
38000
Annuals > 1 > income Statement > pretax Income
-14412000
Annuals > 1 > income Statement > net Income
-14412000
Annuals > 1 > income Statement > eps
-0.07311579203701449
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
197112000
Annuals > 1 > income Statement > income Tax Expense
94000
Annuals > 1 > income Statement > EBITDA
-13787000
Annuals > 1 > income Statement > operating Margin
-1230.6733167082293
Annuals > 1 > income Statement > total Other Income Expense Net
393000
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
2981000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
326000
Annuals > 1 > balance Sheet > inventories
1066000
Annuals > 1 > balance Sheet > total Current Assets
4750000
Annuals > 1 > balance Sheet > property Plant Equipment
949000
Annuals > 1 > balance Sheet > total Assets
5734000
Annuals > 1 > balance Sheet > payables
1363000
Annuals > 1 > balance Sheet > short Term Debt
382000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3649000
Annuals > 1 > balance Sheet > equity
2085000
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-14412000
Annuals > 1 > cash Flow > depreciation
587000
Annuals > 1 > cash Flow > change In Working Capital
-298000
Annuals > 1 > cash Flow > cash From Operations
-13653000
Annuals > 1 > cash Flow > capital Expenditures
177000
Annuals > 1 > cash Flow > cash From Investing
-177000
Annuals > 1 > cash Flow > cash From Financing
3785000
Annuals > 1 > cash Flow > net Change In Cash
-10134000
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.07311579203701449
Annuals > 1 > ratios > PB
833.8263021582734
Annuals > 1 > ratios > ROE
-691.2230215827338
Annuals > 1 > ratios > ROA
-251.3428671084758
Annuals > 1 > ratios > FCF
-13830000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-11.496259351620948
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
638000
Annuals > 2 > income Statement > cost Of Revenue
351000
Annuals > 2 > income Statement > gross Profit
287000
Annuals > 2 > income Statement > operating Expenses
19050000
Annuals > 2 > income Statement > operating Income
-18763000
Annuals > 2 > income Statement > interest Expense
30000
Annuals > 2 > income Statement > pretax Income
-19372000
Annuals > 2 > income Statement > net Income
-19372000
Annuals > 2 > income Statement > eps
-0.09955392932760498
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
194588000
Annuals > 2 > income Statement > income Tax Expense
1412000
Annuals > 2 > income Statement > EBITDA
-18849000
Annuals > 2 > income Statement > operating Margin
-2940.909090909091
Annuals > 2 > income Statement > total Other Income Expense Net
-609000
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
13125000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
182000
Annuals > 2 > balance Sheet > inventories
1294000
Annuals > 2 > balance Sheet > total Current Assets
15129000
Annuals > 2 > balance Sheet > property Plant Equipment
1404000
Annuals > 2 > balance Sheet > total Assets
16569000
Annuals > 2 > balance Sheet > payables
388000
Annuals > 2 > balance Sheet > short Term Debt
359000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4925000
Annuals > 2 > balance Sheet > equity
11644000
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-19372000
Annuals > 2 > cash Flow > depreciation
493000
Annuals > 2 > cash Flow > change In Working Capital
102000
Annuals > 2 > cash Flow > cash From Operations
-16345000
Annuals > 2 > cash Flow > capital Expenditures
311000
Annuals > 2 > cash Flow > cash From Investing
-311000
Annuals > 2 > cash Flow > cash From Financing
-275000
Annuals > 2 > cash Flow > net Change In Cash
-16596000
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.09955392932760498
Annuals > 2 > ratios > PB
147.3948952250086
Annuals > 2 > ratios > ROE
-166.36894537959463
Annuals > 2 > ratios > ROA
-116.9171344076287
Annuals > 2 > ratios > FCF
-16656000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-26.106583072100314
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2569000
Annuals > 3 > income Statement > cost Of Revenue
1315000
Annuals > 3 > income Statement > gross Profit
1254000
Annuals > 3 > income Statement > operating Expenses
18774000
Annuals > 3 > income Statement > operating Income
-17520000
Annuals > 3 > income Statement > interest Expense
1212000
Annuals > 3 > income Statement > pretax Income
-50085000
Annuals > 3 > income Statement > net Income
-50085000
Annuals > 3 > income Statement > eps
-0.25739394095125523
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
194585000
Annuals > 3 > income Statement > income Tax Expense
32731000
Annuals > 3 > income Statement > EBITDA
-48359000
Annuals > 3 > income Statement > operating Margin
-681.9774231218373
Annuals > 3 > income Statement > total Other Income Expense Net
-32565000
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
30365000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
248000
Annuals > 3 > balance Sheet > inventories
1061000
Annuals > 3 > balance Sheet > total Current Assets
33504000
Annuals > 3 > balance Sheet > property Plant Equipment
601000
Annuals > 3 > balance Sheet > total Assets
34140000
Annuals > 3 > balance Sheet > payables
1202000
Annuals > 3 > balance Sheet > short Term Debt
645000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4483000
Annuals > 3 > balance Sheet > equity
29657000
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-50085000
Annuals > 3 > cash Flow > depreciation
514000
Annuals > 3 > cash Flow > change In Working Capital
131000
Annuals > 3 > cash Flow > cash From Operations
-12540000
Annuals > 3 > cash Flow > capital Expenditures
77000
Annuals > 3 > cash Flow > cash From Investing
-77000
Annuals > 3 > cash Flow > cash From Financing
41904000
Annuals > 3 > cash Flow > net Change In Cash
29242000
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.25739394095125523
Annuals > 3 > ratios > PB
57.86963280169943
Annuals > 3 > ratios > ROE
-168.8808712951411
Annuals > 3 > ratios > ROA
-146.70474516695958
Annuals > 3 > ratios > FCF
-12617000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-4.91124951342935
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.020981279418776328
Valuation > metrics > PB
350.3624200159953
Valuation > final Score
20
Valuation > verdict
11578.7% Overvalued
Profitability > metrics > ROE
-92.46606078231787
Profitability > metrics > ROA
-52.17337545126354
Profitability > metrics > Net Margin
-9.526057411995938
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8644757888614222
Risk > metrics > Interest Coverage
-464.582115096627
Risk > final Score
-1810
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.9486887115165334
Liquidity > metrics > Quick Ratio
6.223489167616876
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1418
Prev Risks > 1
-1476
Prev Risks > 2
-1558
Prev Liquidities > 0
79
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:03:07.232Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-26
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.03
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.03
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-14
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.04
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.04
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-30
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.03
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.03
Earnings History > 2 > surprise Percent
-
Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections. In addition, the company offers a pipeline of products for various indications, including burns, ventilator tube, and sinus; and serious and chronic wounds, chronic sinusitis, ventilator-associated pneumonia VAP, and central line bloodstream infections, as well as catheter-associated urinary tract infection. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOndine Biomedical (LSE:OBI) Shares Rise After Study Publication Kalkine Media
Read more →RNS Hotlist with Zak Mir: BZT, UKOG, ADVT, WCAT, VULT, ACG, OBI, FRMI & MPAL Share Talk
Read more →Showing 2 of 8
(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Ondine Biomedical Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.03
EPS Estimate
0
EPS Difference
-0.03
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2024-12-31)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.